Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Cellular Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma (PerCellVac)

NCT02709616 is registered in ClinicalTrials.gov with Guangdong 999 Brain Hospital as lead sponsor.

NCT NCT02709616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Cellular Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma (PerCellVac)
Lead sponsor
Guangdong 999 Brain Hospital
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2016
Completion date
June 30, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma